Pancreas β cell regeneration and type 1 diabetes (Review)

Experimental and Therapeutic Medicine

Volumn 9, Issue 3, 2015, Pages 653-657

  Wu, Jinxiao ^a   Yang, Xiyan ^b   Chen, Bin ^a   Xu, Xiuping ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes mellitus; Endocrine pancreas; Type 1 diabetes; cell regeneration

Indexed keywords

CARBOXYPEPTIDASE A1; CD45 ANTIGEN; CYCLIN D2; CYCLIN DEPENDENT KINASE 4; GLUCAGON; INSULIN; KI 67 ANTIGEN; MIXED LINEAGE LEUKEMIA PROTEIN; MYC PROTEIN; NEUROGENIN 3; PANCREAS TRANSCRIPTION FACTOR 1A; PEPTIDES AND PROTEINS; SURVIVIN; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

APOPTOSIS; CELL MATURATION; CELL REGENERATION; CELL TRANSDIFFERENTIATION; CELLS BY BODY ANATOMY; CHRONIC PANCREATITIS; CYSTIC FIBROSIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; REVIEW;

EID: 84922022071     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.2163     Document Type: Review

References (61)

1. Desgraz R, Bonal C and Herrera PL: β-cell regeneration: the pancreatic intrinsic faculty. Trends Endocrinol Metab 22: 34-43, 2011.
2. Zhang Y, Sun W, Zhang F, Huang J and Fan Z: Pancreaticobiliary maljuction combining with pancreas divisum: report of four cases. Exp Ther Med 7: 8-10, 2014.
3. Prado CL, Pugh-Bernard AE, Elghazi L, Sosa-Pineda B and Sussel L: Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development. Proc Natl Acad Sci USA 101: 2924-2929, 2004.
4. Guo L, Xu Y, Zhang X, Luo Y, Liu W and Chen B: Insulinization: a promising strategy for the treatment of type 2 diabetes mellitus. Exp Ther Med 6: 1300-1306, 2013.
5. Granata R, Baragli A, Settanni F, Scarlatti F and Ghigo E: Unraveling the role of the ghrelin gene peptides in the endocrine pancreas. J Mol Endocrinol 45: 107-118, 2010.
6. Meier JJ, Köhler CU, Alkhatib B, Sergi C, Junker T, Klein HH, Schmidt WE and Fritsch H: Beta-cell development and turnover during prenatal life in humans. Eur J Endocrinol 162: 559-568, 2010.
7. Ackermann AM and Gannon M: Molecular regulation of pancreatic beta-cell mass development, maintenance, and expansion. J Mol Endocrinol 38: 193-206, 2007.
8. Murtaugh LC: Pancreas and beta-cell development: from the actual to the possible. Development 134: 427-438, 2007.
9. Teitelman G: On the origin of pancreatic endocrine cells, proliferation and neoplastic transformation. Tumour Biol 14: 167-173, 1993.
10. Herrera PL: Adult insulin-and glucagon-producing cells differentiate from two independent cell lineages. Developmen 127: 2317-2322, 2000.
11. Pictet RL, Clark WR, Williams RH and Rutter WJ: An ultrastructural analysis of the developing embryonic pancreas. Dev Biol 29: 436-467, 1972.
12. Zhou Q, Law AC, Rajagopal J, Anderson WJ, Gray PA and Melton DA: A multipotent progenitor domain guides pancreatic organogenesis. Dev Cell 13: 103-114, 2007.
13. Johansson KA, Dursun U, Jordan N, Gu G, Beermann F, Gradwohl G and Grapin-Botton A: Temporal control of neurogenin3 activity in pancreas progenitors reveals competence windows for the generation of different endocrine cell types. Dev Cell 12: 457-465, 2007.
14. Gradwohl G, Dierich A, LeMeur M and Guillemot F: Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci USA 97: 1607-1611, 2000.
15. Maulis M and Gianani R: Beta-cell regeneration in human pancreas: the lessons of pancreatic pathology. Adv Exp Med Biol 771: 310-318, 2012.
16. Kusama Y, Takayanagi S, Tategu M and Yoshida K: Expression and tissue distribution of human X-linked armadillo repeat containing-6. Exp Ther Med 1: 395-399, 2010.
17. Kaczirek K and Niederle B: Nesidioblastosis: an old term and a new understanding. World J Surg 28: 1227-1230, 2004.
18. Dor Y, Brown J, Martinez OI and Melton DA: Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429: 41-46, 2004.
19. Brennand K, Huangfu D and Melton D: All beta cells contribute equally to islet growth and maintenance. PLoS Biol 5: e163, 2007.
20. Teta M, Rankin MM, Long SY, Stein GM and Kushner JA: Growth and regeneration of adult beta cells does not involve specialized progenitors. Dev Cell 12: 817-826, 2007.
21. Scaglia L, Cahill CJ, Finegood DT and Bonner-Weir S: Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology 138: 1736-1741, 1997.
22. Teta M, Long SY, Wartschow LM, Rankin MM and Kushner JA: Very slow turnover of beta-cells in aged adult mice. Diabetes 54: 2557-2567, 2005.
23. Salpeter SJ, Klein AM, Huangfu D, Grimsby J and Dor Y: Glucose and aging control the quiescence period that follows pancreatic beta cell replication. Development 137: 3205-3213, 2010.
24. Farilla L, Hui H, Bertolotto C, Kang E, Bulotta A, Di Mario U and Perfetti R: Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology 143: 4397-4408, 2002.
25. Krishnamurthy J, Ramsey MR, Ligon KL, Torrice C, Koh A, Bonner-Weir S and Sharpless NE: p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443: 453-457, 2006.
26. Rieck S and Kaestner KH: Expansion of beta-cell mass in response to pregnancy. Trends Endocrinol Metab 21: 151-158, 2010.
27. Georgia S and Bhushan A: Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J Clin Invest 114: 963-968, 2004.
28. Kushner JA, Ciemerych MA, Sicinska E, Wartschow LM, Teta M, Long SY, Sicinski P and White MF: Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth. Mol Cell Biol 25: 3752-3762, 2005.
29. Marzo N, Mora C, Fabregat ME, Martín J, Usac EF, Franco C, Barbacid M and Gomis R: Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes. Diabetologia 47: 686-694, 2004.
30. Marzo N, Ortega S, Stratmann T, García A, Ríos M, Giménez A, Gomis R and Mora C: Cyclin-dependent kinase 4 hyperactivity promotes autoreactivity in the immune system but protects pancreatic cell mass from autoimmune destruction in the nonobese diabetic mouse model. J Immunol 180: 1189-1198, 2008.
31. Grouwels G, Cai Y, Hoebeke I, Leuckx G, Heremans Y, Ziebold U, Stangé G, Chintinne M, Ling Z, Pipeleers D, et al: Ectopic expression of E2F1 stimulates beta-cell proliferation and function. Diabetes 59: 1435-1444, 2010.
32. Milne TA, Hughes CM, Lloyd R, Yang Z, Rozenblatt-Rosen O, Dou Y, Schnepp RW, Krankel C, Livolsi VA, Gibbs D, et al: Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc Natl Acad Sci USA 102: 749-754, 2005.
33. Karnik SK, Hughes CM, Gu X, Rozenblatt-Rosen O, McLean GW, Xiong Y, Meyerson M and Kim SK: Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proc Natl Acad Sci USA 102: 14659-14664, 2005.
34. Dor Y and Melton DA: Facultative endocrine progenitor cells in the adult pancreas. Cell 132: 183-184, 2008.
35. Li Y, Peng M and Gong G: Evaluation of the revised versus the simplified scoring system in patients with autoimmune hepatitis. Exp Ther Med 7: 131-136, 2014.
36. Inada A, Nienaber C, Katsuta H, Fujitani Y, Levine J, Morita R, Sharma A and Bonner-Weir S: Carbonic anhydrase II-positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birth. Proc Natl Acad Sci USA 105: 19915-19919, 2008.
37. Bonner-Weir S, Li WC, Ouziel-Yahalom L, Guo L, Weir GC and Sharma A: Beta-cell growth and regeneration: replication is only part of the story. Diabetes 59: 2340-2348, 2010.
38. Gianani R, Putnam A, Still T, Yu L, Miao D, Gill RG, Beilke J, Supon P, Valentine A, Iveson A, et al: Initial results of screening of nondiabetic organ donors for expression of islet autoantibodies. J Clin Endocrinol Metab 91: 1855-1861, 2006.
39. Martin-Pagola A, Sisino G, Allende G, Dominguez-Bendala J, Gianani R, Reijonen H, Nepom GT, Ricordi C, Ruiz P, Sageshima J, et al: Insulin protein and proliferation in ductal cells in the transplanted pancreas of patients with type 1 diabetes and recurrence of autoimmunity. Diabetologia 51: 1803-1813, 2008.
40. Liu H, Guz Y, Kedees MH, Winkler J and Teitelman G: Precursor cells in mouse islets generate new beta-cells in vivo during aging and after islet injury. Endocrinology 151: 520-528, 2010.
41. Kodama S, Toyonaga T, Kondo T, Matsumoto K, Tsuruzoe K, Kawashima J, Goto H, Kume K, Kume S, Sakakida M and Araki E: Enhanced expression of PDX-1 and Ngn3 by exendin-4 during beta cell regeneration in STZ-treated mice. Biochem Biophys Res Commun 327: 1170-1178, 2005.
42. Thorel F, Népote V, Avril I, Kohno K, Desgraz R, Chera S and Herrera PL: Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature 464: 1149-1154, 2010.
43. Chung CH, Hao E, Piran R, Keinan E and Levine F: Pancreatic β-cell neogenesis by direct conversion from mature α-cells. Stem Cells 28: 1630-1638, 2010.
44. Bending D, Zaccone P and Cooke A: Inflammation and type one diabetes. Int Immunol 24: 339-346, 2012.
45. Collombat P, Xu X, Ravassard P, Sosa-Pineda B, Dussaud S, Billestrup N, Madsen OD, et al: The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells. Cell 138: 449-462, 2009.
46. Gelling RW, Du XQ, Dichmann DS, Romer J, Huang H, Cui L, Obici S, Tang B, Holst JJ, Fledelius C, et al: Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci USA 100: 1438-1443, 2003.
47. Guney MA and Gannon M: Pancreas cell fate. Birth Defects Res C Embryo Today 87: 232-248, 2009.
48. Lee JH, Jo J, Hardikar AA, Periwal V and Rane SG: Cdk4 regulates recruitment of quiescent beta-cells and ductal epithelial progenitors to reconstitute beta-cell mass. PLoS One 5: e8653, 2010.
49. Richardson SJ, Willcox A, Bone AJ, Morgan NG and Foulis AK: Immunopathology of the human pancreas in type-I diabetes. Semin Immunopathol 33: 9-21, 2011.
50. Baiu D, Merriam F and Odorico J: Potential pathways to restore β-cell mass: pluripotent stem cells, reprogramming, and endogenous regeneration. Curr Diab Rep 11: 392-401, 2011.
51. Gianani R, Campbell-Thompson M, Sarkar SA, Wasserfall C, Pugliese A, Solis JM, Kent SC, Hering BJ, West E, Steck A, et al: Dimorphic histopathology of long-standing childhood-onset diabetes. Diabetologia 53: 690-698, 2010.
52. Meier JJ, Bhushan A, Butler AE, Rizza RA and Butler PC: Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 48: 2221-2228, 2005.
53. Liu L, Gong L, Zhang Y and Li N: Glycolysis in Panc-1 human pancreatic cancer cells is inhibited by everolimus. Exp Ther Med 5: 338-342, 2013.
54. Lonardo E, Frias-Aldeguer J, Hermann PC and Heeschen C: Pancreatic stellate cells form a niche for cancer stem cells and promote their self-renewal and invasiveness. Cell Cycle 11: 1282-1290, 2012.
55. Li M and Ikehara S: Bone marrow stem cell as a potential treatment for diabetes. J Diabetes Res 2013: 329596, 2013.
56. Rodriguez Rilo HL, Ahmad SA, D'Alessio D, Iwanaga Y, Kim J, Choe KA, Moulton JS, Martin J, Pennington LJ, Soldano DA, et al: Total pancreatectomy and autologous islet cell transplantation as a means to treat severe chronic pancreatitis. J Gastrointest Surg 7: 978-989, 2003.
57. Yatagai T, Suzuki T and Tobe T: Changes in microvascular structure of the fibrotic pancreas and their influence on pancreatic endocrine function. Int J Pancreatol 4: 291-301, 1989.
58. Klöppel G, Reinecke-Lüthge A and Koschoreck F: Focal and Diffuse Beta Cell Changes in Persistent Hyperinsulinemic Hypoglycemia of Infancy. Endocr Pathol 10: 299-304, 1999.
59. Rahier J, Guiot Y and Sempoux C: Persistent hyperinsulinaemic hypoglycaemia of infancy: a heterogeneous syndrome unrelated to nesidioblastosis. Arch Dis Child Fetal Neonatal Ed 82: F108-F112, 2000.
60. Kapoor RR, James C and Hussain K: Hyperinsulinism in developmental syndromes. Endocr Dev 14: 95-113, 2009.
61. Bae GS, Park KC, Koo BS, Jo IJ, Choi SB, Song HJ and Park SJ: Nardostachys jatamansi inhibits severe acute pancreatitis via mitogen-activated protein kinases. Exp Ther Med 4: 533-537, 2012.